Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Coronary artery bypass grafting is a more invasive procedure where surgeons use blood vessels from another part of the body ...

Chunhui Xu and her team leveraged the ISS National Laboratory ® for cardiac cell research to accelerate the development of cell-based regenerative therapies that could one day reverse heart damage.

Feb. 13, 2025 — Testosterone treatment significantly reduces mortality ... Improves Survival in Patients With a New Type of Heart Disease Feb. 13, 2025 — A multi-institutional research team ...

The risk of dying from heart complications is significantly higher in the first 2 years after a colorectal cancer diagnosis, ...

Heart disease remains the leading cause of death worldwide, with atherosclerosis—a condition where fatty plaques build up in ...

In response to this urgent issue, UCLA Health has established the South Asian Heart Program, a pioneering initiative aimed at ...

Professor Park Hyuk-jin of the Department of Circulatory Medicine appeared on YouTube 'Jiamji' at Hwasun Chonnam National ...

Affecting 1 in 500 people, hypertrophic cardiomyopathy is a condition in which the walls of the left ventricle, the heart's ...

The Government's recently launched AI Action Plan, focusing on creating a National Data Library, marks a pivotal moment for ...